HC (n = 66) | NAFLD Patients | |||
---|---|---|---|---|
Lean (n = 67) | Overweight (n = 55) | Obese (n = 48) | ||
Sex (m/f) | 42/24 | 41/26 | 36/19 | 30/18 |
Age (y) | 40.03 ± 10.17 | 48.38 ± 12.13a | 47.74 ± 13.30a | 49.18 ± 12.25a |
BMI (kg/m 2) | 20.41 ± 2.06 | 22.58 ± 0.75a | 26.19 ± 1.03ab | 29.49 ± 2.17abc |
WC (cm) | 78.23 ± 9.11 | 88.25 ± 6.03a | 93.51 ± 7.79ab | 98.06 ± 9.65ab |
Body fat (%) | 20.23 ± 4.82 | 25.25 ± 4.93a | 30.79 ± 3.90ab | 31.32 ± 3.07ab |
SBP (mmHg) | 114.74 ± 10.44 | 131.91 ± 19.92a | 130.87 ± 14.90a | 126.44 ± 10.55a |
DBP (mmHg) | 79.42 ± 7.93 | 84.75 ± 7.57a | 88.30 ± 8.72a | 85.94 ± 6.53a |
FBG (mmol/L) | 5.28 ± 0.46 | 6.22 ± 1.66a | 5.54 ± 0.70b | 6.28 ± 1.33ac |
Fasting insulin (IU/ml) | 5.79 ± 2.77 | 8.16 ± 3.14a | 8.91 ± 4.35a | 11.89 ± 5.76abc |
HOMA-IR | 1.38 ± 0.74 | 2.33 ± 1.15a | 2.18 ± 1.10a | 3.59 ± 2.82abc |
TC (mmol/L) | 4.40 ± 0.66 | 5.31 ± 0.93a | 5.19 ± 0.77a | 5.35 ± 1.07a |
TG (mmol/L) | 0.86 ± 0.30 | 1.68 ± 0.66a | 1.87 ± 1.13a | 2.17 ± 1.27ab |
HDL-C (mmol/L) | 1.69 ± 0.31 | 1.51 ± 0.27a | 1.54 ± 0.36a | 1.31 ± 0.26abc |
LDL-C (mmol/L) | 2.50 ± 0.52 | 3.29 ± 0.78a | 3.20 ± 0.73a | 3.30 ± 0.86a |
ALT (U/L) | 15.21 ± 7.55 | 24.06 ± 10.92a | 25.11 ± 15.84a | 28.11 ± 14.94a |
AST (U/L) | 18.65 ± 4.45 | 22.21 ± 6.10a | 23.92 ± 7.93a | 22.15 ± 6.09a |
ALP (U/L) | 64.56 ± 15.87 | 72.88 ± 17.96a | 67.61 ± 15.54 | 69.19 ± 19.34 |
GGT (U/L) | 19.66 ± 12.93 | 46.32 ± 40.05a | 45.84 ± 43.95a | 48.48 ± 24.75a |